Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Short seller - 80 National Bank and 57 Interactive Broker
View:
Post by Photoman77 on Nov 02, 2021 4:36pm

Short seller - 80 National Bank and 57 Interactive Broker

Lack of news has short sellers licking their lips. Fake basher accounts spamming these boards

NilStocks - Profile create Nov 2, 2021
Trippingagain1 - Profile created Nov 1, 2021
Commandment - Profile create Nov 1, 2021

Off course Liked2Think and 4real4ever are the usual basher suspects

Watch out for these 5. Make you believe the world is falling

Truth is, Aristotle sales figures will soon be released.

Hold on to your shares.
Comment by frewil11 on Nov 03, 2021 9:15am
I would be surprised if they had any Aristotle sales in Q3 .
Comment by brad129 on Nov 03, 2021 10:07am
According to Rebecca they were performing "pad for" tests in Q3  
Comment by Liked2Think on Nov 03, 2021 10:31am
and what has changed that would lead you to believe that is true? "tests"  ok so technically they could had done 2 of them and that could be considered "tests" When a ceo can say $30M in revenue and get $0 what weight does an email from the company hold?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities